Filing excerpt
Capital expenditures for the remainder of fiscal 2026 are expected to be approximately $7 million.
The company has budgeted approximately $7 million for capital expenditures for the rest of fiscal 2026.
Filing excerpt
Capital expenditures for the remainder of fiscal 2026 are expected to be approximately $7 million.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qcapexIncreaseGet every 10-Q signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f6f45866-bc27-45cf-8f2a-6ec4a216b1bd returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "f6f45866-bc27-45cf-8f2a-6ec4a216b1bd",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-12T09:24:56.699+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "The company has budgeted approximately $7 million for capital expenditures for the rest of fiscal 2026. These investments are aimed at increasing production capacity to support anticipated sales growth, indicating available budget for facility upgrades, equipment, and related operational technology.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "Expected capital expenditures for the remainder of fiscal 2026",
"dollar_millions": 7
},
"summary": "Bio-Techne plans $7M in capital expenditures for remainder of fiscal 2026 to increase capacity.",
"excerpts": "Capital expenditures for the remainder of fiscal 2026 are expected to be approximately $7 million.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926056302/tech-20260331x10q.htm",
"filing_date": "2026-05-06",
"filing_year": 2026,
"fiscal_year": 0,
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/f6f45866-bc27-45cf-8f2a-6ec4a216b1bd \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.